Biggest News Aggregation in the World
📰 Paces Advisors News

Page 9 - Paces Advisors News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Paces Advisors. Real-time updates on events, politics, business and more.

iShares 7-10 Year Treasury Bond ETF (NASDAQ:IEF) Sees Large Decline in Short Interest

IShares 7-10 Year Treasury Bond ETF (NASDAQ:IEF – Get Free Report) saw a significant decrease in short interest in December. As of December 15th, there was short interest totalling 18,350,000 shares, a decrease of 12.7% from the November 30th total of 21,020,000 shares. Based on an average daily volume of 12,945,300 shares, the short-interest ratio […]
United States Paces Advisors Inc Fc Advisory Asset Management Massmutual Trust Co Goalvest Advisory

Hoylecohen LLC Raises Stake in Novo Nordisk A/S (NYSE:NVO)

Hoylecohen LLC increased its stake in Novo Nordisk A/S (NYSE:NVO – Free Report) by 11.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,220 shares of the company’s stock after purchasing an additional 920 shares during the quarter. Hoylecohen LLC’s holdings in […]
Hong Kong United States Novo Nordisk Paces Advisors Inc Securities Exchange Commission Pacific Center

NXP Semiconductors (NASDAQ:NXPI) Rating Increased to Buy at StockNews.com

StockNews.com upgraded shares of NXP Semiconductors (NASDAQ:NXPI – Free Report) from a hold rating to a buy rating in a research note released on Tuesday morning. A number of other analysts also recently issued reports on the stock. Evercore ISI lowered their price objective on shares of NXP Semiconductors from $240.00 to $235.00 in a […]
United States Jennifer Wuamett Martino Ronald Semiconductors Price Performance Semiconductors Company Profile Semiconductors Dividend Announcement
Source: wkrb13.com

Cantor Fitzgerald Reaffirms Overweight Rating for Novo Nordisk A/S (NYSE:NVO)

Cantor Fitzgerald restated their overweight rating on shares of Novo Nordisk A/S (NYSE:NVO – Free Report) in a research report sent to investors on Monday, PriceTargets.com reports. Cantor Fitzgerald also issued estimates for Novo Nordisk A/S’s FY2023 earnings at $2.65 EPS and FY2024 earnings at $3.35 EPS. Other analysts have also issued research reports about […]
Novo Nordisk Paces Advisors Inc Cantor Fitzgerald Asset Management Sunbelt Securities Inc Corefirst Bank

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science